Targeting CD44 in mast cell regulation

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 1, 2010, Pages 31-43

  Tanaka, Satoshi ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Allergy; CD44; Hyaluronan; Mast cell; Skin

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

CELL DIFFERENTIATION; CHRONIC INFLAMMATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC REGULATION; HUMAN; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MAST CELL; NONHUMAN; REVIEW; TUMOR IMMUNITY; UPREGULATION;

ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HUMANS; MAST CELLS; MICE; RATS;

EID: 72549096829     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903473186     Document Type: Review

References (86)

1. Metz M, Grimbaldeston MA, Nakae S, et al. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007;217:304-328
2. Bischoff SC. Roles of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007;7:93-104
3. Kalesnikoff J, Galli S. New developments in mast cell biology. Nat Immunol 2008;9:1215-1223
4. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079
5. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989;7:59-76
6. Chen C, Grimbaldeston MA, Tsai M, et al. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 2005;102:11408-11413
7. Arinobu Y, Iwasaki H, Gurish MF, et al. Development checkpoints of basophil/ mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005;102:18105-18110
8. Jawdat DM, Albert EJ, Rowden G, et al. IgE-mediated mast cell activation induces Langerhans cell migiration in vivo. J Immunol 2004;173:5257-5282
9. Bryce PJ, Miller ML, Miyajima I, et al. Immune sensitization in the skin is enhanced by antigen-independent effects. Immunity 2004;20:381-392
10. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006;442:997-1002
11. Takano H, Nakazawa S, Okuno Y, et al. Establishment of the culture model system that reflects the process of terminal differentiation of connective tissue-type mast cells. FEBS Lett 2008;582:1444-1450
12. Takano H, Nakazawa S, Shirata N, et al. Involvement of CD44 in mast cell proliferation during terminal differentiation. Lab Invest 2009;89:446-455
13. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142
14. Maurer M, Wedemeyer J, Metz M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004;432:512-516
15. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008;8:478-486
16. Sayed BA, Christy A, Quirion MR, et al. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008;26:705-739
17. Theoharides TC, Conti P. Mast cells: the JEKYL and HYDE of tumor growth. Trend Immunol 2004;25:235-241
18. Stelekati E, Bahri R, D'Orlando O, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009;31:665-676
19. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/WV mice and their increase by bone marrow transplantation. Blood 1978;52:447-452
20. Grimbaldeston MA, Chen CC, Piliponsky AM, et al. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-848
21. Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989;10:381-386
22. Galli SJ, Kitamura Y. Genetically mast-cell-deficient W/WV and Sl/Sld mice. Am J Pathol 1987;127:191-198
23. Berrozpe G, Timokhina I, Yukl S, et al. The Wsh, W57, and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 1999;94:2658-2666
24. Lantz CS, Boesiger J, Song CH, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998;392:90-93
25. Theiner G, Gessner A, Lutz MB. The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immnology 2006;211:463-472
26. Chen R, Ning G, Zhao ML, et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001;108:1151-1158
27. Nelson KC, Zhao M, Schroeder PR, et al. Role of different pathways of the complement cascade in experimental bullous pephigoid. J Clin Invest 2006;116:2892-2900
28. Yamada N, Matsushima H, Tagaya Y, et al. Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J Invest Dermatol 2003;121:1425-3229.
29. Tsai M, Wedemeyer J, Ganiatsas S, et al. In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc Natl Acad Sci USA 2000;97:9186-9190
30. Levi-Schaffer F, Austen KF, Gravallese PM, et al. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic changes of the mast cells. Proc Natl Acad Sci USA 1986;83:6485-6488
31. Ogasawara T, Murakami M, Suzuki-Nishimura T, et al. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in responses to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. J Immunol 1997;158:393-404
32. Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FceRI or FcgammaRI. Leuk Res 2003;27:677-682 (Pubitemid 36683255)
33. Saito H, Ebisawa M, Tachioto H, et al. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157:343-350 (Pubitemid 26190566)
34. Kambe N, Hiramatsu H, Shimonaka M, et al. Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood 2004;103:860-867
35. Saito H, Kato A, Matsumoto K, et al. Culture of human mast cells from peripheral blood progenitors. Nat Protoc 2006;1:2178-2183
36. Dayton ET, Caulfield JP, Hein A, et al. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells. J Immunol 1989;42:4307-4313
37. Mizuno K, Tolmachova T, Ushakov DS, et al. Rab27b regulates mast cell granule dynamics and secretion. Traffic 2007;8:883-892
38. Kusche-Gullberg M, Kjellén L. Sulfotransferase in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 2003;13:605-611
39. Humphries DE, Wong GW, Friend DS. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999;400:769-772
40. Forsberg E, Pejler G, Ringvall M, et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999;400:773-776
41. Malbec O, Daeron M. The mast cell IgG receptors and their roles in tissue inflammation. Immunol Rev 2007;217:206-221
42. Fleming TJ, Donnadieu E, Song CH, et al. Negative regulation of FceRI-mediated degranulation by CD81. J Exp Med 1997;186:1307-1314
43. Tam SY, Tsai M, Souwaert JN, et al. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat Immunol 2004;5:844-852
44. Aridor M, Rajmilevich G, Beaven MA, et al. Activation of exocytosis by the heterotrimeric G protein Gi3. Nature 1993;262:1569-1572
45. Piliponsky AM, Gleich GJ, Nagler A, et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003;101:1898-1904
46. Nakae S, Suto H, Berry GJ, et al. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007;109:3640-3648
47. Walsh JC, DeKoter RP, Lee HJ, et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fate. Immunity 2002;17:665-676
48. Migliaccio AR, Rana RA, Sanchez M, et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 2003;197:281-296
49. Masuda A, Hashimoto K, Yokoi T, et al. Essential role of GATA transcript factors in the activation of mast cells. J Immunol 2007;178:360-368
50. Cellot S, Sauvageau G. Gfi1: another piece in the HSC puzzle. Trend Immunol 2005;26:68-71
51. Rodel B, Tavassoli K, Karsunky H, et al. The zinc finger protein Gfi1 can enhance STAT3 signaling by interacting with the STAT3 inhibitors PIAS3. EMBO J 2000;19:5845-5855
52. Sonnenblick A, Levy C, Razin E. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol 2004;24:10584-10592
53. Kitamura Y, Morii E, Jippo T, et al. Regulation of mast cell phenotype by MITF. Int Arch Allergy Immunol 2002;127:106-109 (Pubitemid 34264195)
54. Doyen V, Rubio M, Braun D, et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 2003;198:1277-1283
55. Lamy L, Foussat A, Brown EJ, et al. Interaction between CD47 and thrombospondin reduce inflammation. J Immunol 2007;178:5930-5939
56. D'Souza-Schorey C, Chavrier P. ARF proteins: role in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006;7:347-358
57. Vitale N, Chasserot-Golaza S, Bailly Y, et al. Calcium-regulated exocytosis of dense-core vesicles requires the activation of ADP-ribosylation factor (ARF) 6 by ARF nucleotide binding site opener at the plasma membrane. J Cell Biol 2002;159:79-89
58. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rav Cancer 2004;4:528-539
59. Weissman B, Mayer K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc 1954;76:1753-1757
60. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003;4:33-45
61. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001;7:213-221
62. Schulz T, Schmacher U, Prehm P. Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem 2007;282:20999-21004
63. Ghannadan M, Baghestanian M, Wimazal F, et al. Phenotypic characterization of human skin mast cells by combined staining with Toluidine blueand CD antibodies. J Invest Dermatol 1998;111:689-695
64. Fukui M, Whittlesey K, Metcalfe DD, et al. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid. Clin Immunol 2000;94:173-178
65. Kataoka TR, Nishizawa Y. Stat4 suppresses the proliferation of connective tissue-type mast cells. Lab Invest 2008;88:856-864
66. Lee JL, Wang MJ, Chen JY. Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. J Cell Biol 2009;185:949-957
67. Jung JR, Kim H, Jeun SS, et al. The phosphorylation status of merlin is important for regulating the Ras-ERK pathway. Mol Cells 2005;20:196-200
68. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001;15:968-980
69. Timokhina I, Kissel H, Stella G, et al. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J 1998;17:6250-6262
70. Klein EA, Campbell LE, Kothapalli D, et al. Joint requirement for Rac and ERK activities underlies the mid-G1 phase induction of cyclin D1 and S phase entry in both epithelial and mesenchymal cells. J Biol Chem 2008;283:30911-30918
71. Kothapalli D, Flowers J, Xu T, et al. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 2007;283:31823-31829
72. Label L, Smith L, Risberg B, et al. Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am J Physiol 1989;256:H1524-31
73. Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007;217:19-37
74. Kaya G, Rodriguez I, Jorcano JL, et al. Selective suppression of CD44 in keratinocytes of mice bearing an antisense driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impair keratinocyte proliferation. Genes Dev 1997;11:996-1007
75. Nedvetzki S, Gonen E, Assayag N, et al. RHAMM, receptor for hyaluronan-mediated motility, compensate for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA 2004;101:18081-18086
76. Zeidler A, Brauer R, Thoss K, et al. Therapeutic effects of antibodies against adhesion molecules in murine collagen type II-induced arthritis. Autoimmunity 1995;21:245-252
77. Camp RL, Scheynius A, Johansson C, et al. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 1993;178:497-507
78. Brocke S, Piercy C, Steinman L, et al. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA 1999;96:6896-6901
79. Rafi-Janajreh AQ, Chen D, Schmits R, et al. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J Immunol 1999;163:1619-1627
80. Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science 2002;296:155-158
81. Liang J, Jiang D, Griffith J, et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 2007;178:2469-2475
82. Nagasaka A, Matsue H, Matsushima H, et al. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008;38:489-499
83. Kim Y, Lee YS, Hahn JH, et al. Hyaluronic acid targets CD44 and inhibits FceRI signaling involving PKCd, Rac1, ROS, and MAPK to exert anti-allergic effect. Mol Immunol 2008;45:2537-2547
84. Tsuchiya S, Tachida Y, Segi-Nishida E, et al. Characterization of gene expression profiles for different types of mast cells pooled from mouse stomach subregions by an RNA amplification method. BMC Genomics 2009;10:35. Published online 20 January 2009, doi:10.1186/1471-2164-10-35
85. Zheng Z, Katoh S, He Q, et al. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol 1995;130:485-495
86. Hodge-Dufour J, Noble PW, Horton MR, et al. Induction of IL-12 and chemokines by hyaluronan requires adhesion-depndent priming of resident but not elicited macrophages. J Immunol 1997;159:2492-2500